August 27th 2025
NRX-100, a preservative-free ketamine, is granted expanded access for treatment of suicidal ideation in depression, offering new hope for patients.
Patient Case #1: 27-Year-Old Woman With Bipolar Disorder
Experts in psychiatry review the case of a 27-year-old woman who presents for evaluation of a complex depressive disorder.
Watch